[{"id":"kim-tae-won","kind":"person","name":"Tae Won Kim","route":"/people/kim-tae-won/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/people/asia-pacific.ts","type":"changed","fields":[{"field":"tldr","before":"\"Korea's leading colorectal cancer trialist, an investigator on the fruquintinib, trifluridine/tipiracil, and anti-EGFR studies used worldwide.\"","after":"\"Tae Won Kim is Korea's leading colorectal cancer trialist, an investigator on the fruquintinib, trifluridine/tipiracil, and anti-EGFR studies used worldwide.\""}]},{"id":"kim-tae-won","kind":"person","name":"Tae Won Kim","route":"/people/kim-tae-won/","commit":"9b4eb0eb88","date":"2026-09-08","author":"Jude Gomila","message":"Add Asia-Pacific, Canada, Brazil, and IARC/WHO people (91 person entities)","file":"src/data/people/asia-pacific.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"role"},{"field":"institutionId"},{"field":"institutions"},{"field":"specialisms"},{"field":"tldr"},{"field":"summary"},{"field":"profiles"},{"field":"papers"},{"field":"cancers"},{"field":"drugs"},{"field":"trials"}]}]